Capacity Bio

Palo Alto, United States

Capacity Bio is a therapeutics company that is focused on mitophagy.

$35.0M raised

Mar 2023

Series A

Top Investors

Insight PartnersRA Capital ManagementRemiges Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Capacity Bio raised?

Capacity Bio has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Who are Capacity Bio's investors?

Capacity Bio's investors include Insight Partners, RA Capital Management, Remiges Ventures.

Where is Capacity Bio headquartered?

Capacity Bio is headquartered in Palo Alto, United States.

What does Capacity Bio do?

Capacity Bio is a therapeutics company that is focused on mitophagy.

What stage is Capacity Bio at?

Capacity Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 31, 2023.

MLA

"Capacity Bio — Funding & Investors." VCBacked, March 31, 2023, https://www.vcbacked.co/company/capacity-bio. Accessed June 4, 2026.

APA

VCBacked. (2023). Capacity Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/capacity-bio

Wikipedia (cite web)

{{cite web |title=Capacity Bio — Funding & Investors |url=https://www.vcbacked.co/company/capacity-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 31, 2023.